None listed
Conditions
Brief summary
The primary purpose of this study is to develop an intervention in community pharmacy which gives community pharmacies a role in the primary prevention of cardiovascular disease within a multidisciplinary context.
Interventions
Pharmacists will provide counselling to patients at monthly intervals for five months and liaise with general practitioners to improve medications management, medication adherence and lifestyle management. General practitioners (GPs) will be informed of patient's involvement in research, provided with a written copy of the the pharmacy treatment plan, and asked for comment. They will also be informed verbally or in writing of any recommended chages to patient medication.
Sponsors
Monash University
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
50 Years to 74 Years
Healthy volunteers
No
Inclusion criteria
Patients aged 50-74 years, taking one or more medicines for cholesterol or hypertension, and without established cardiovascular disease or a cardiovascular event
Exclusion criteria
1. patients with a complex debilitating coexisting medical condition (e.g. mental illness, end-stage cancer) 2. Previously-identified diabetes 3. Target organ damage 4. Any cognitive impairment 5. Dependent patients relying on a carer or living in a residential aged care facility 6. Recent hospital inpatients who were medical admissions and discharged less than four weeks prior to recruitment 7. Non-English speaking 8. Living more than 40 km from a participating pharmacy 9. Patients who have received a Home Medication Review (HMR) in the past 12 months 10. Patients whose GP has deemed them inappropriate for this intervention Patients of GPs who express a desire not to have any involvement with this project
Outcome results
None listed